Case report: Therapeutic response for new daily persistent headache by a tumor necrosis factor alpha antagonist, lithium
New daily persistent headache (NDPH) is an uncommon, treatment-resistant primary headache disorder that was first describe by Vanast in 1986 as a benign syndrome. Elevated TNF-alpha levels on CSF of NDPH patients as a possible cause of this disease. TNF-alpha inhibitors like doxycycline, venlafaxine...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-03-01
|
| Series: | Cephalalgia Reports |
| Online Access: | https://doi.org/10.1177/25158163211000316 |